Chinese tech giant ByteDance – best known as the parent of social media app TikTok – has completed a $290 million financing ...

Curium's radioligand therapy Bexlutry has been approved in the US as a generic – or 'radioligand equivalent' (RLE) – of ...

Wales has recommended ALK's EURneffy nasal spray as the first needle-free option for the emergency treatment of severe ...

The expedited IND programme will allow trial sponsors to partner with a set of qualified research institutions (QRIs) to review IND applications in rolling parts, rather than all at once, and aims to ...

A pharmaceutical company sends a patient a reminder to refill a prescription. A specialty pharmacy calls to coordinate ...

AI company Anthropic has launched a new large language model (LLM) – Claude Fable 5 – claiming its capabilities as a tool for drug discovery and scientific research gives it a big lead over other ...

The Danish Group stated that the new corporate culture – dubbed 'The Novo Way' – centres around four Cs; namely, customer ...

GSK reported good clinical trial results with two of its lung cancer therapies – Jideytro and risvutatug rezetecan (ris-rez) ...

UK-headquartered Beacon Therapeutics has raised a whopping $170 million in second-round financing that will be used to advance a gene therapy for an inherited cause of blindness through a pivotal ...

The offer is legally conditioned upon the private equity company's Respighi BidCo vehicle securing at least a two-thirds ...

The planned IPO comes after Electra raised $183 million in a Series C that completed last October, as it started dosing ...

BioNTech and partner OncoC4's anti-CTLA-4 immunotherapy gotistobart almost doubled survival in a trial involving patients with a hard-to-treat form of lung cancer, ahead of a pivotal readout due next ...